Christine E Brown

This inventor holds 22 USPTO granted patents and 29 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Beckman Research Institute, City of Hope, Leland Stanford Junior University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine E Brown. Retrieved from https://idiyas.com/inventor/christine-e-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 29)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 9 (Patent Applications = 27)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 89(Granted Patents)

Location History:

Pasadena, CA (US) (2017 - 2023)
Duarte, CA (US) (2017 - 2024)

Company Filing History:

21 out of 692

Beckman Research Institute, City of Hope

patents

1 out of 5,519

Leland Stanford Junior University

patents

1 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptors

T Cell Therapy

Cancer Treatment

IL13Rα2

CD6 Targeting

PSCA

HER2

Endogenous Viral Vaccine

Costimulatory T Cells

Autoimmune Disorders

CNS Malignancies

T Cell Modification

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590137 - MEDITOPE-ENABLED T CELLS (2026-03-31),

2. 12565535 - CHIMERIC ANTIGEN RECEPTORS TARGETED TO PSCA (2026-03-03),

3. 12551557 - TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13RALPHA2 POSITIVE MALIGNANCIES (2026-02-17),

4. 12522667 - CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE (2026-01-13),

5. 12472233 - Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System (2025-11-18),

6. 12419954 - Targeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 positive malignancies (2025-09-23),

7. 12281151 - CD6 targeted chimeric antigen receptors for treatment of certain autoimmune disorders (2025-04-21),

8. 12161714 - Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy (2024-12-10),

9. 12115189 - T cells for expression of chimeric antigen receptors and other receptors (2024-10-15),

10. 11918606 - CD123-specific chimeric antigen receptor redirected t cells and methods of their use (2024-03-05),

11. 11701405 - Chimeric antigen receptors and methods for reducing toxicity (2023-07-18),

12. 11690908 - Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy (2023-07-04),

13. 11466097 - Chimeric antigen receptors targeted to PSCA (2022-10-11),

14. 11230577 - Chimeric antigen receptors containing a chlorotoxin domain (2022-01-25),

15. 11197919 - Chimeric antigen receptors targeting HER2 (2021-12-14),

Title: The Innovative Journey of Christine E Brown

Introduction: Christine E Brown, a talented inventor based in Duarte, CA, has made significant contributions to the world of innovation with her creative ideas and groundbreaking inventions.

Latest Patents: Christine E Brown holds several patents in various fields, including technology, healthcare, and consumer products. Her most recent patent focuses on a revolutionary medical device designed to improve patient outcomes in surgical procedures.

Career Highlights: With a career spanning over two decades, Christine E Brown has established herself as a leading figure in the innovation industry. She has worked with top research institutions and companies to bring her ideas to life, earning recognition for her forward-thinking approach.

Collaborations: Throughout her career, Christine E Brown has collaborated with renowned inventors, patent attorneys, and research institutions to enhance her projects. These collaborations have led to the development of cutting-edge technologies that have had a positive impact on society.

Conclusion: Christine E Brown's passion for innovation and dedication to pushing the boundaries of what is possible have solidified her reputation as a pioneering inventor. Her work continues to inspire the next generation of innovators to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.